Pfizer
PFE
2,257 hedge funds and large institutions have $185B invested in Pfizer in 2018 Q3 according to their latest regulatory filings, with 126 funds opening new positions, 812 increasing their positions, 1,073 reducing their positions, and 56 closing their positions.
125% more first-time investments, than exits
New positions opened: 126 | Existing positions closed: 56
48% more funds holding in top 10
Funds holding in top 10: 176 → 260 (+84)
22% more capital invested
Capital invested by funds: $152B → $185B (+$33.8B)
15% more call options, than puts
Call options by funds: $1.32B | Put options by funds: $1.14B
2% more funds holding
Funds holding: 2,205 → 2,257 (+52)
0.02% more ownership
Funds ownership: 75.69% → 75.71% (+0.02%)
24% less repeat investments, than reductions
Existing positions increased: 812 | Existing positions reduced: 1,073
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$1.92B |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$548M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$353M |
| 4 |
State Street
Boston,
Massachusetts
|
+$274M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$269M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$460M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$377M |
| 3 |
Mitsubishi UFJ Trust & Banking
Tokyo,
Japan
|
-$319M |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
-$218M |
| 5 |
BlackRock
New York
|
-$184M |
PFE Hedge Fund Activity: Q3 2018 in Review
2,257 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q3 2018, worth a combined $185B — up 22% from $152B a quarter earlier.
Buyers outnumbered sellers: 126 funds opened new PFE positions and 56 closed out — a net gain of 70 holders — while 812 added to existing stakes and 1,073 trimmed.
The largest buyer was Capital World Investors, adding an estimated $1.92B. The largest seller was Franklin Resources, cutting an estimated $460M.
- 2,257 institutional investors held Pfizer (PFE) as of Q3 2018, up from 2,205 in Q2 2018.
- Funds reported $185B of Pfizer stock for Q3 2018, up 22% quarter-over-quarter.
- 126 funds opened new Pfizer positions in Q3 2018 and 56 closed out, a net change of +70 holders.
- The largest Pfizer buyer in Q3 2018 was Capital World Investors, an estimated $1.92B added.
- The largest Pfizer seller in Q3 2018 was Franklin Resources, an estimated $460M sold.
Based on aggregated 13F filings for Q3 2018.